The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, yielding billions in revenue , its intellectual property lapse created a https://linkedbookmarker.com/story7028980/sildenafil-and-big-pharma-a-uncertain-investment